Novavax

YTD

ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.

CEO

John C.s Jacobs

CEOJohn C.s Jacobs

Employees

952

Employees952

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1987

Founded1987

Employees

952

Employees952

NVAX Key Statistics

Market cap

1.39B

Market cap1.39B

Price-Earnings ratio

3.79

Price-Earnings ratio3.79

Dividend yield

—

Dividend yield—

Average volume

4.29M

Average volume4.29M

High today

$8.60

High today$8.60

Low today

$8.16

Low today$8.16

Open price

$8.33

Open price$8.33

Volume

3.28M

Volume3.28M

52 Week high

$15.22

52 Week high$15.22

52 Week low

$5.01

52 Week low$5.01

NVAX News

Simply Wall St 11h

Novavax: Exploring Valuation After Analyst Upgrades and Renewed Investor Interest

Advertisement Most Popular Narrative: 31.6% Undervalued Novavax (NVAX) is catching the attention of many investors lately, and it is not just because of anoth...

Simply Wall St 6d

Novavax Draws Spotlight as ACIP Reviews Covid Vaccine—Is Market Position Set to Shift?

The newly restructured Advisory Committee on Immunization Practices (ACIP) recently convened to review updated Covid vaccines from Novavax, Pfizer, and Moderna,...

TipRanks 7d

Challenging Market Dynamics and Regulatory Hurdles Lead to Sell Rating for Novavax

Analyst Alec Stranahan from Bank of America Securities maintained a Sell rating on Novavax and keeping the price target at $7.00. Elevate Your Investing Strateg...

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

12.5%

Sell

37.5%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.